Literature DB >> 2553724

Inhibition of calpain by a synthetic oligopeptide corresponding to an exon of the human calpastatin gene.

M Maki1, H Bagci, K Hamaguchi, M Ueda, T Murachi, M Hatanaka.   

Abstract

Calpastatin is a widely distributed endogenous inhibitor protein specifically acting on calpain (Ca2+-dependent cysteine endopeptidase). The inhibitor consists of four inhibitory domains (Domains 1-4) with mutually homologous sequences. NH2-terminal Domain L is non-homologous, and all domains have 120-140 residues each. A human calpastatin genomic DNA clone was isolated using a previously obtained human calpastatin cDNA probe. Sequence analysis has revealed that the clone contains Domain 1 and segments of neighboring domains (Domains L and 2). Each of three highly conserved, restricted regions within Domain 1 was located on separate exons, 1A, 1B, and 1C. Exon 2A, corresponding to the first exon of Domain 2, is homologous to Exon 1A and follows Exon 1D of Domain 1. A 27-residue peptide encoded by Exon 1B, including a 12-residue middle conserved sequence, was chemically synthesized and tested for protease inhibitory activities. The synthetic peptide showed strong inhibition against calpain I (low Ca2+-requiring form), and calpain II (high Ca2+-requiring form), but no inhibition against papain or trypsin. These results indicated that Exon 1B forms a self-sufficient functional subdomain of the calpastatin inhibitory domain.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2553724

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Inhibition of calpain blocks platelet secretion, aggregation, and spreading.

Authors:  K Croce; R Flaumenhaft; M Rivers; B Furie; B C Furie; I M Herman; D A Potter
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

2.  The sensitivity of c-Jun and c-Fos proteins to calpains depends on conformational determinants of the monomers and not on formation of dimers.

Authors:  M Pariat; C Salvat; M Bébien; F Brockly; E Altieri; S Carillo; I Jariel-Encontre; M Piechaczyk
Journal:  Biochem J       Date:  2000-01-01       Impact factor: 3.857

3.  The effects of calpain inhibition on IkB alpha degradation after activation of PBMCs: identification of the calpain cleavage sites.

Authors:  Kurt Schaecher; Jean-Michel Goust; Naren L Banik
Journal:  Neurochem Res       Date:  2004-07       Impact factor: 3.996

4.  NMR relaxation studies on the hydrate layer of intrinsically unstructured proteins.

Authors:  Mónika Bokor; Veronika Csizmók; Dénes Kovács; Péter Bánki; Peter Friedrich; Peter Tompa; Kálmán Tompa
Journal:  Biophys J       Date:  2004-12-21       Impact factor: 4.033

5.  Role of calpain in skeletal-muscle protein degradation.

Authors:  J Huang; N E Forsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

6.  Proteolysis by calpains: a possible contribution to degradation of p53.

Authors:  M Pariat; S Carillo; M Molinari; C Salvat; L Debüssche; L Bracco; J Milner; M Piechaczyk
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

7.  Cathepsin L Mediates the Degradation of Novel APP C-Terminal Fragments.

Authors:  Haizhi Wang; Nianli Sang; Can Zhang; Ramesh Raghupathi; Rudolph E Tanzi; Aleister Saunders
Journal:  Biochemistry       Date:  2015-04-28       Impact factor: 3.162

8.  Moderation of calpain activity promotes neovascular integration and lumen formation during VEGF-induced pathological angiogenesis.

Authors:  Mien V Hoang; Janice A Nagy; Joan E B Fox; Donald R Senger
Journal:  PLoS One       Date:  2010-10-25       Impact factor: 3.240

9.  Binding-induced folding transitions in calpastatin subdomains A and C.

Authors:  Zoltán Mucsi; Ferenc Hudecz; Miklós Hollósi; Peter Tompa; Peter Friedrich
Journal:  Protein Sci       Date:  2003-10       Impact factor: 6.725

10.  HER2 regulates Brk/PTK6 stability via upregulating calpastatin, an inhibitor of calpain.

Authors:  Midan Ai; Songbo Qiu; Yang Lu; Zhen Fan
Journal:  Cell Signal       Date:  2013-05-22       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.